Cogent Biosciences Inc (NASDAQ:COGT) currently has a daily average trading volume of 1.10M but it saw 1817376 shares traded in last market. With a market cap of 1.12B USD, the company’s current market price of $10.24 came rising about 3.23 while comparing to the previous closing price of $9.92. In past 52 weeks, the stock remained buoying in the range of price level as high as $13.23 and as low as $3.67. In the recent trading on the day, stock has struck highest price mark of $9.92 while lowest mark touched by it was $10.24.
Taking a look at 20-day trading activity of Cogent Biosciences Inc (COGT) gives us an average price of $9.22, while its current price level is -22.60% below from 52-week high level whereas it is 179.02% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $8.95 while that of 200 days or SMA-200 reads an average of $7.27. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.59% during that period while stretching the period over a month that decreases to 6.39%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 65.53 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Robert W. Baird which downgraded the stock as “Neutral” in its note to investors issued on February 26, 2024, recommending a price target of between $14 and $8 for it. Wedbush also issued its recommendations for the stock as it downgraded the price target for the stock is $5.
Over the week, COGT’s stock price is moving 20.19% up while it is 12.40% when we observe its performance for the past one month. Year-to-date it is 74.15% up and over the past year, the stock is showing a downside performance of -14.31%.
The company is expected to be releasing its next quarterly report on 2024-Oct-31, for which analysts forecasted an EPS of -0.57 while estimate for next year EPS is -2.31. In next quarter, company is expected to be making quarterly sales of $nan as analysts are expecting the sales for current fiscal year at $nan and seeing the company making $nan in sales next year. Moreover, analysts are in estimates of $nan for current-quarter revenue.
Currently, Cogent Biosciences Inc’s total number of outstanding shares is 86.12M with 0.12% of that held by the insiders while 112.32% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -58.23% and return on equity (ROE) at -62.92%. Stock’s beta reads 1.71. Stock has a price to book (P/B) ratio of 4.32. Its return on asset (ROA) is -55.22% on average.
